(Q42984229)

12 November 2017

title

Frequency and significance of antibody to hepatitis C virus in severe corticosteroid-treated autoimmune chronic active hepatitis (English)

1 reference

12 November 2017

1 reference

1 reference

A J Czaja

1

1 reference

12 November 2017

H F Taswell

series ordinal

2

1 reference

12 November 2017

J Rakela

series ordinal

3

1 reference

12 November 2017

C M Schimek

series ordinal

4

1 reference

12 November 2017

language of work or name

English

0 references

publication date

1 June 1991

1 reference

12 November 2017

1 reference

12 November 2017

volume

66

1 reference

12 November 2017

issue

6

1 reference

12 November 2017

page(s)

572-582

1 reference

Detection of a Liver-Membrane Autoantibody in HBsAg-negative Chronic Active Hepatitis

12 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960515-1

Detection of antibodies directed against a liver-specific membrane lipoprotein in patients with acute and chronic active hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960515-1

Immune mechanisms in autoimmune chronic active hepatitis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960515-1

Immunological Aspects of Chronic Active Hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960515-1

Auto-immune chronic active hepatitis: a specific entity? The negative argument

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960515-1

Severe chronic active liver disease. Prognostic significance of initial morphologic patterns

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960515-1

Autoimmune chronic active hepatitis masquerading as acute hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960515-1

7 January 2021

Active chronic hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960515-1

Natural history, clinical features, and treatment of autoimmune hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960515-1

Autoimmune chronic active hepatitis developing after acute type B hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960515-1

Persistent measles virus genome in autoimmune chronic active hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960515-1

Hepatocellular carcinoma in corticosteroid-treated severe autoimmune chronic active hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960515-1

Etiology of sporadic hepatitis B surface antigen-negative hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960515-1

Clinical, Epidemiological and Prognostic Aspects of Hepatitis “Non-A, Non-B”—a Comparison with Hepatitis A and B

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960515-1

The Chronic Sequelae of Non-A, Non-B Hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960515-1

Primary hepatocellular carcinoma following non-A, non-B posttransfusion hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960515-1

Primary hepatocellular carcinoma after chronic non-A, non-B post-transfusion hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960515-1

Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960515-1

An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960515-1

Hepatitis C virus antibodies among risk groups in Spain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960515-1

Type 2 autoimmune hepatitis and hepatitis C virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960515-1

Hepatitis C virus antibodies in chronic active hepatitis: pathogenetic factor or false-positive result?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960515-1

Clinical features and prognostic implications of severe corticosteroid-treated cryptogenic chronic active hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960515-1

Frequency and significance of antibody to hepatitis C virus in severe corticosteroid-treated cryptogenic chronic active hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960515-1

A classification of chronic hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960515-1

Complete resolution of inflammatory activity following corticosteroid treatment of HBsAg-negative chronic active hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960515-1

Prednisone for chronic active liver disease: dose titration, standard dose, and combination with azathioprine compared

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960515-1

Detection of hepatitis C viral sequences in non-A, non-B hepatitis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960515-1

Drug-induced chronic liver disease, with emphasis on chronic active hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960515-1

Inadequate antibody response to hBAg or suppressor T-cell defect in development of active chronic hepatitis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960515-1

Autoimmunity in chronic active hepatitis and diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960515-1

Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960515-1

Hazards of interferon therapy for HBV-seronegative chronic hepatitis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960515-1

10.1016/S0025-6196(12)60515-1

7 January 2021

Identifiers

DOI

1 reference

12 November 2017

1 reference